ZS Pharma Company Profile (NASDAQ:ZSPH)

About ZS Pharma

ZS Pharma logoZS Pharma, Inc. is a biopharmaceutical company focused on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. The Company's zirconium silicate technology allows it to create selective ion traps that can reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. The Company has completed Phase III development of its product candidate, sodium zirconium cyclosilicate (ZS-9), for the treatment of hyperkalemia, a life-threatening condition in which elevated levels of potassium increase the risk of muscle dysfunction, including cardiac arrhythmias and sudden cardiac death. The Company has completed three clinical studies with ZS-9 for patients with hyperkalemia, including patients with chronic kidney disease (CKD), heart failure (HF), diabetes and those on renin-angiotensin aldosterone system (RAAS) inhibitor therapy.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ZSPH
  • CUSIP:
Key Metrics:
  • Previous Close: $89.98
  • 50 Day Moving Average: $85.57
  • 200 Day Moving Average: $66.48
  • 52-Week Range: $37.52 - $91.24
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.71
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to ZS Pharma:

Analyst Ratings

Consensus Ratings for ZS Pharma (NASDAQ:ZSPH) (?)
Ratings Breakdown: 5 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $90.00 (0.02% upside)

Analysts' Ratings History for ZS Pharma (NASDAQ:ZSPH)
DateFirmActionRatingPrice TargetDetails
11/18/2015Citigroup Inc.DowngradeBuy -> Neutral$90.00View Rating Details
11/9/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$75.00 -> $90.00View Rating Details
11/9/2015Morgan StanleyDowngradeOverweight -> Equal Weight$79.00 -> $90.00View Rating Details
11/9/2015Credit Suisse Group AGDowngradeOutperform -> Neutral$67.00 -> $90.00View Rating Details
11/6/2015William BlairDowngradeOutperform -> Market PerformView Rating Details
9/11/2015BMO Capital MarketsReiterated RatingBuy$70.00 -> $83.00View Rating Details
(Data available from 10/25/2014 forward)


Earnings History for ZS Pharma (NASDAQ:ZSPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2015Q315($1.04)($0.41)ViewN/AView Earnings Details
8/6/2015($0.90)($1.30)ViewN/AView Earnings Details
5/11/2015Q115($0.86)($1.05)ViewN/AView Earnings Details
3/13/2015Q414($0.75)($0.98)ViewN/AView Earnings Details
11/10/2014Q314($0.74)($0.81)ViewN/AView Earnings Details
8/14/2014Q214($0.66)($4.72)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ZS Pharma (NASDAQ:ZSPH)
Current Year EPS Consensus Estimate: $-4.68 EPS
Next Year EPS Consensus Estimate: $-5.08 EPS


Dividend History for ZS Pharma (NASDAQ:ZSPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ZS Pharma (NASDAQ:ZSPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2015Todd A. CreechCFOSell70,000$49.84$3,488,800.00View SEC Filing  
6/8/2015Alta Partners Viii, L.P.Major ShareholderSell175,427$57.86$10,150,206.22View SEC Filing  
6/4/2015Alta Partners Viii, L.P.Major ShareholderSell111,597$57.30$6,394,508.10View SEC Filing  
6/2/2015Alta Partners Viii, L.P.Major ShareholderSell296,423$58.00$17,192,534.00View SEC Filing  
6/23/2014A/S NovoInsiderBuy275,000$18.00$4,950,000.00View SEC Filing  
6/23/2014Guy P NohraDirectorBuy200,000$18.00$3,600,000.00View SEC Filing  
6/23/2014Park Bioventures Lp DevonMajor ShareholderBuy160,000$18.00$2,880,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for ZS Pharma (NASDAQ:ZSPH)
News IconZS Pharma, Inc. (ZSPH) Updated Broker Price Targets - The De Soto Edge (NASDAQ:ZSPH)
www.desotoedge.com - October 19 at 7:53 PM
News IconLatest Analyst Ratings For ZS Pharma, Inc. (ZSPH) - The De Soto Edge (NASDAQ:ZSPH)
desotoedge.com - September 30 at 5:34 AM
News IconLatest Analyst Ratings For ZS Pharma, Inc. (ZSPH) (NASDAQ:ZSPH)
www.desotoedge.com - September 29 at 8:05 PM
News IconPlacing ZS Pharma, Inc. (NASDAQ:ZSPH) Shares Under the Microscope - National Daily Press (NASDAQ:ZSPH)
www.nationaldailypress.com - September 10 at 5:13 AM
News IconPlacing ZS Pharma, Inc. (NASDAQ:ZSPH) Shares Under the Microscope - Post News (NASDAQ:ZSPH)
www.kentuckypostnews.com - September 9 at 5:13 AM
News IconZS Pharma, Inc. (NASDAQ:ZSPH) From The Analysts Point of View - National Daily Press (NASDAQ:ZSPH)
www.nationaldailypress.com - September 8 at 7:52 PM
seekingalpha.com logoWhat To Do With Your Relypsa Winnings - Seeking Alpha (NASDAQ:ZSPH)
seekingalpha.com - July 22 at 8:14 PM
smarteranalyst.com logoHC Wainwright Weighs In On Two Healthcare Stocks: Relypsa Inc (RLYP) and Biogen Inc (BIIB) - Smarter Analyst (NASDAQ:ZSPH)
www.smarteranalyst.com - July 22 at 8:14 PM
investors.com logoBid war beckons after Galenica snaps up Relypsa, brokers say - Proactive Investors USA & Canada (NASDAQ:ZSPH)
www.proactiveinvestors.com - July 21 at 11:18 AM
News IconCrowd Rating and Earnings Recap for ZS Pharma, Inc. (NASDAQ:ZSPH) - Telanagana Press (NASDAQ:ZSPH)
telanaganapress.com - July 15 at 1:48 PM
News IconZS Pharma, Inc. (NASDAQ:ZSPH) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ZSPH)
telanaganapress.com - July 14 at 12:03 PM
News IconZS Pharma, Inc. (NASDAQ:ZSPH) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:ZSPH)
www.engelwooddaily.com - July 12 at 10:19 AM
News IconTrading Performance and Target Watch for ZS Pharma, Inc. (NASDAQ:ZSPH) - Press Telegraph (NASDAQ:ZSPH)
presstelegraph.com - July 12 at 10:19 AM
News IconWall Street Ratings and Target Price Views on ZS Pharma, Inc. (NASDAQ:ZSPH) - Telanagana Press (NASDAQ:ZSPH)
telanaganapress.com - July 8 at 11:15 AM
ftsenews.co.uk logoNew Broker Ratings For ZS Pharma, Inc. (ZSPH) - FTSE News (NASDAQ:ZSPH)
www.ftsenews.co.uk - July 1 at 8:26 PM
News IconZS Pharma, Inc. (NASDAQ:ZSPH) Company Rating and Target Watch - Telanagana Press (NASDAQ:ZSPH)
telanaganapress.com - June 30 at 8:39 PM
News IconZS Pharma, Inc. (NASDAQ:ZSPH) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:ZSPH)
www.engelwooddaily.com - June 27 at 8:11 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 87.00 On ZS Pharma, Inc. (ZSPH) - Fiscal Standard (NASDAQ:ZSPH)
www.fiscalstandard.com - June 18 at 5:19 AM
News IconStock Review and Earnings Check on ZS Pharma, Inc. (NASDAQ:ZSPH) - HNN (NASDAQ:ZSPH)
hintsnewsnetwork.com - June 1 at 11:33 AM
News IconNext Weeks Broker Price Targets For ZS Pharma, Inc. (ZSPH) - Share Trading News (NASDAQ:ZSPH)
www.sharetrading.news - May 30 at 7:46 PM
fool.com logoShares Of Relypsa Inc. Are Surging Again -- Here's Why (NASDAQ:ZSPH)
www.fool.com - May 27 at 11:42 AM
bloomberg.com logoAstraZeneca's Good Deal Turns Bad (NASDAQ:ZSPH)
www.bloomberg.com - May 27 at 11:40 AM
finance.yahoo.com logoAstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA (NASDAQ:ZSPH)
finance.yahoo.com - May 27 at 7:47 AM
News IconLatest Analysts Reports On ZS Pharma, Inc. (ZSPH) - Risers & Fallers (NASDAQ:ZSPH)
www.risersandfallers.com - February 26 at 10:50 AM
uk.finance.yahoo.com logoQuestor share tip: AstraZeneca faces Crestor crunch in year ahead (NASDAQ:ZSPH)
uk.finance.yahoo.com - February 5 at 3:59 AM
News IconPrice Target Update On ZS Pharma, Inc. (ZSPH) - Risers & Fallers (NASDAQ:ZSPH)
www.risersandfallers.com - February 2 at 1:01 PM
gurufocus.com logoThe Gabelli ABC Fund Merger and Arbitrage Shareholder Commentary for Q4 (NASDAQ:ZSPH)
www.gurufocus.com - January 29 at 12:53 PM
investornewswire.com logoZS Pharma, Inc. (NASDAQ:ZSPH) - Stock Sentiment And ABR Update - Investor Newswire (NASDAQ:ZSPH)
www.investornewswire.com - January 22 at 7:06 PM
News IconZS Pharma, Inc. (ZSPH) Recent Analyst Updates - Risers & Fallers (NASDAQ:ZSPH)
www.risersandfallers.com - January 22 at 11:58 AM
finance.yahoo.com logoActelion says selexipag to enter U.S. market in January (NASDAQ:ZSPH)
finance.yahoo.com - December 22 at 1:32 AM
noodls.com logoAstraZeneca completes acquisition of ZS Pharma (NASDAQ:ZSPH)
www.noodls.com - December 21 at 7:08 PM
moodys.com logoAstraZeneca PLC -- Moody's downgrades AstraZeneca to A3, stable outlook (NASDAQ:ZSPH)
www.moodys.com - December 18 at 12:47 PM
biz.yahoo.com logoZS PHARMA, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur (NASDAQ:ZSPH)
biz.yahoo.com - December 17 at 5:07 PM
sg.finance.yahoo.com logoAstraZeneca buys most of Acerta for $4 billion to add cancer drug (NASDAQ:ZSPH)
sg.finance.yahoo.com - December 17 at 11:09 AM
bizjournals.com logoAstraZeneca confirms interest in a possible $5B purchase (NASDAQ:ZSPH)
www.bizjournals.com - December 14 at 9:30 AM
finance.yahoo.com logoZS PHARMA, INC. Financials (NASDAQ:ZSPH)
finance.yahoo.com - December 8 at 1:17 PM
investors.com logoRelypsa Stock Jumps On Buyout Rumors (NASDAQ:ZSPH)
news.investors.com - December 4 at 3:31 PM
insidermonkey.com logoZS Pharma Inc (ZSPH) Generating Strong Interest from Top Money Managers (NASDAQ:ZSPH)
www.insidermonkey.com - December 2 at 3:44 PM
insidermonkey.com logoAre Hedge Funds Dumping Amicus Therapeutics, Inc. (FOLD)? (NASDAQ:ZSPH)
www.insidermonkey.com - November 25 at 2:19 PM
insidermonkey.com logoHedge Fund Sentiment Has This to Say About These Moves on 3 Healthcare Stocks (NASDAQ:ZSPH)
www.insidermonkey.com - November 20 at 11:57 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ZS Pharma, Inc. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to AstraZeneca PLC -- ZSPH (NASDAQ:ZSPH)
finance.yahoo.com - November 13 at 12:49 PM


ZS Pharma (NASDAQ:ZSPH) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by MarketBeat.com Staff